Abstract
Sesquiterpene lactones (SLs) are biologically active compounds found in various medicinal plants. Although the compounds are reported to possess numerous biological activities, but the most important is their immunoregulatory role in inflammatory cells. This is because 1) over-activation of inflammatory cells secretes a large amount of different pro-inflammatory mediators such as cytokines, nitric oxide (NO) and prostaglandin (PG)E2 and 2) SLs can modulate these phenomena effectively through inhibiting the activation pathway of nuclear factor (NF)-κB via the reactivity of some functional groups in SLs such as α-methylene-γ- lactone. This review, therefore, discusses in detail the molecular mechanism and structural features of SLs in blocking NF-κB activation with a general introduction of NF-κB and proposes the possibility that SLs can be developed pharmaceutically useful drugs against NF-κB-mediated diseases and that they can be chemically modified to improve their anti-NF-κB efficacy.
Keywords: Sesquiterpene lactones, NF-κB, I-κB, cytokines, inflammatory mediators, structure-activity relationship study
Current Enzyme Inhibition
Title: Sesquiterpene Lactones as a Potent Class of NF-κB Activation Inhibitors
Volume: 2 Issue: 4
Author(s): Jae Youl Cho
Affiliation:
Keywords: Sesquiterpene lactones, NF-κB, I-κB, cytokines, inflammatory mediators, structure-activity relationship study
Abstract: Sesquiterpene lactones (SLs) are biologically active compounds found in various medicinal plants. Although the compounds are reported to possess numerous biological activities, but the most important is their immunoregulatory role in inflammatory cells. This is because 1) over-activation of inflammatory cells secretes a large amount of different pro-inflammatory mediators such as cytokines, nitric oxide (NO) and prostaglandin (PG)E2 and 2) SLs can modulate these phenomena effectively through inhibiting the activation pathway of nuclear factor (NF)-κB via the reactivity of some functional groups in SLs such as α-methylene-γ- lactone. This review, therefore, discusses in detail the molecular mechanism and structural features of SLs in blocking NF-κB activation with a general introduction of NF-κB and proposes the possibility that SLs can be developed pharmaceutically useful drugs against NF-κB-mediated diseases and that they can be chemically modified to improve their anti-NF-κB efficacy.
Export Options
About this article
Cite this article as:
Youl Cho Jae, Sesquiterpene Lactones as a Potent Class of NF-κB Activation Inhibitors, Current Enzyme Inhibition 2006; 2 (4) . https://dx.doi.org/10.2174/157340806778699299
DOI https://dx.doi.org/10.2174/157340806778699299 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective
Current Pharmaceutical Design Ultra-deformable Liposomes as Flexible Nanovesicular Carrier to Penetrate Versatile Drugs Transdermally
Nanoscience & Nanotechnology-Asia Guinea Pig Model of Infectious Disease - Viral Infections
Current Drug Targets Multi-targeting Andrographolide and its Natural Analogs as Potential Therapeutic Agents
Current Topics in Medicinal Chemistry Aspirin as a Chemoprevention Agent for Colorectal Cancer
Current Drug Metabolism MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches
Current Pharmaceutical Biotechnology Conventional and Alternative Treatment Options for Allergic Rhinitis
Current Respiratory Medicine Reviews Current Applications of Biopolymer-based Scaffolds and Nanofibers as Drug Delivery Systems
Current Pharmaceutical Design Some Peculiar Effects of NO-Synthase Inhibition on the Structure and Function of Cardiovascular System
Current Pharmaceutical Biotechnology Nonsteroidal Anti-Inflammatory Drugs in Experimental Parkinsonian Models and Parkinsons Disease
Current Pharmaceutical Design Small Molecule Toxins Targeting Tumor Receptors
Current Pharmaceutical Design Chemical Modifications of Two Polysaccharides as Drug Carriers
Current Organic Synthesis Effects of Excitotoxic Lesion with Inhaled Anesthetics on Nervous System Cells of Rodents
Current Pharmaceutical Design Triheptanoin Supplementation to Ketogenic Diet Curbs Cognitive Impairment in APP/PS1 Mice Used as a Model of Familial Alzheimer’s Disease
Current Alzheimer Research A Review on Leukemia and iPSC Technology: Application in Novel Treatment and Future
Current Stem Cell Research & Therapy Inflammatory Diseases - New Compounds and Treatments
Current Organic Chemistry Induction of a Robust Humoral Response using HIV-1 VLP<sup>MPER-V3</sup> as a Novel Candidate Vaccine in BALB/c Mice
Current HIV Research Microglia:Neuroprotective and Neurotrophic Cells in the Central Nervous System
Current Drug Targets - Cardiovascular & Hematological Disorders Negative Regulators of Toll-like Receptor 4-Mediated Macrophage Inflammatory Response
Current Pharmaceutical Design The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation
Current Topics in Medicinal Chemistry